Del Mar Medical Pensions

Del Mar Medical Pensions

Home
Membership Lead
AngelList
Portfolio Review
Archive
About
The Mindset of a Modern Entrepreneur: Insights from UC San Diego’s Office of Innovation and Commercialization
Greg Horowitt shares a human-centered approach to entrepreneurship from UC San Diego, emphasizing authenticity, resilience, collaboration, and…
From Physics to Innovation: Dr. Victoria Cajipe on Translating Research into Real-World Impact
Explore how San Diego’s innovation ecosystem turns scientific research into real-world impact through collaboration, entrepreneurship, and UCSD…
Pioneering Innovation: UC San Diego's Blueprint for Entrepreneurial Success
UC San Diego drives innovation, led by Dr. Paul Roben, whose work in commercialization and entrepreneurship defines the university’s forward-thinking…
The Smartest Moves I’ve Seen Doctors Make—And Why We’re Putting Them Inside Defined Benefit Plans
Discover 5 smart wealth-building strategies doctors use inside defined benefit plans for tax savings, growth, and PBGC-backed retirement security.
Smart Pensions for Smart Doctors: Customizing the Climb to Retirement
Defined benefit plans give physicians the flexibility to retire on their own terms—whether contributing early or scaling up later in their career.
From Vision to Venture: Building San Diego’s Life Science Future, Together
Phase Two Ventures gathers San Diego’s biotech leaders to spark connection, back real science, and build lasting companies in the life sciences…
1
A New Era for Biogen and LA Biotech: Christopher Viehbacher’s Vision at LABEST 2024
Biogen CEO Christopher Viehbacher outlines a bold new vision at LABEST 2024, highlighting innovation in immunology, rare disease, and biotech…
Biotech's Boldest Minds on Innovation, Immunology, and Cell Therapy
Biotech leaders at LABEST share bold insights on cell therapy, immunology, and scaling innovation from lab to clinic in a future-shaping panel…
Biogen CEO Christopher Viehbacher at LABEST
LABEST keynote speaker Arie Belldegrun introduces Biogen CEO Christopher Viehbacher, spotlighting vision, biotech leadership, and the future of…
From Deep Freeze to Funding Thaw: Insights from Leaders in Life Science Venture Capital
A panel of top VCs at LABEST 2024 share how early-stage biotech startups can raise capital, survive funding freezes, and attract strategic investment.
Made in LA: Case Studies in Bio Success
Biotech leaders at LABEST 2024 share how Los Angeles powers innovation in oncology, AI pain tech, and CAR-T—proving LA is now a true life sciences hub.
The Vision and Impact of the California Institute for Immunology and Immunotherapy at UCLA Research Park
UCLA's new Immunology Institute unites science, AI, and philanthropy to revolutionize healthcare and launch the next biotech innovation hub in LA.
© 2025 Del Mar Medical Devices
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture